Your browser doesn't support javascript.
loading
Novel nanomicelle butenafine formulation for ocular drug delivery against fungal keratitis: In Vitro and In Vivo study.
Lu, Ping; Liang, Zhen; Zhang, Zhen; Yang, Jingjing; Song, Fei; Zhou, Tianyang; Li, Jingguo; Zhang, Junjie.
Afiliación
  • Lu P; Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Liang Z; Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Zhang Z; Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Yang J; Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Song F; Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Zhou T; Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Li J; Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Zhang J; Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China. Electronic address: zhangjunjie@zzu.edu.cn.
Eur J Pharm Sci ; 192: 106629, 2024 Jan 01.
Article en En | MEDLINE | ID: mdl-37918544

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Queratitis / Antifúngicos Límite: Animals Idioma: En Revista: Eur J Pharm Sci Asunto de la revista: FARMACIA / FARMACOLOGIA / QUIMICA Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Queratitis / Antifúngicos Límite: Animals Idioma: En Revista: Eur J Pharm Sci Asunto de la revista: FARMACIA / FARMACOLOGIA / QUIMICA Año: 2024 Tipo del documento: Article País de afiliación: China